Doctors describe a rare esophageal perforation in a patient on semaglutide, a condition that can be deadly when diagnosis comes late.
Recap by typeshit. Full story at Cureus.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
CDC figures say nearly three in four US adults felt very tired some days lately. A local practice promotes peptides and NAD for energy, claims that are its own.
TradingKey sees MariTide, a GLP-1 and GIP antibody-peptide conjugate, as Amgen's biggest growth bet, with Q2 revenue at $10.1 billion and guidance raised.
Loading…